Literature DB >> 25462471

Risk for osteopenia and osteoporosis in institution-dwelling individuals with intellectual and/or developmental disabilities.

Lan-Ping Lin1, Shang-Wei Hsu2, Chung-Hui Yao3, Wei-Ju Lai3, Pei-Jung Hsu4, Jia-Ling Wu5, Cordia M Chu6, Jin-Ding Lin7.   

Abstract

The purpose of this study was to investigate the prevalence of and contributing factors to osteopenia and osteoporosis among people with intellectual disabilities (ID) or/and developmental disabilities (DD) residing in a disability institution in Taiwan. The present study was conducted at one disability institution in Taiwan and recruited 184 institutionalized residents with ID and/or DD (115 men and 69 women aged 18-72 years) for analysis. For all residents with ID and/or DD, information was obtained about their age, gender, level of ID, BMI, and bone mineral density (BMD). BMD is a measurement of calcium levels in bones that can estimate the risk of osteoporosis and bone fractures. Bone tests were divided into three outcome categories based on their calcaneal BMD T-scores: Normal BMD, a T-score≧-1; Osteopenia, -2.5≦T-score<-1; and Osteoporosis, a T-score<-2.5. The results revealed that 46.2% of cases were normal and that 27.7% and 26.1% of cases had osteopenia and osteoporosis, respectively. Multiple logistic regression analyses found that male gender (OR=2.482, 95% CI=1.04-5.93, p<0.05), age≧40 years (OR=3.051, 95% CI=1.07-8.69, p<0.05) and being overweight/obese (OR=0.395, 95% CI=0.17-0.93, p<0.05) were more likely to be associated with osteoporosis. Another model indicated that males (OR=2.169, 95% CI=1.12-4.19, p<0.05) and those aged≧40 years (OR=3.026, 95% CI=1.32-7, p<0.01) tended to have an increased risk for osteopenia and osteoporosis. To improve the bone quality of individuals with ID or/and DD and to decrease the occurrence of osteopenia and osteoporosis, this study highlights that we should pay much attention to the potential risk factors for bone quality in these vulnerable populations.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone mineral density; Developmental disability; Institution; Intellectual disability; Osteopenia; Osteoporosis

Year:  2014        PMID: 25462471     DOI: 10.1016/j.ridd.2014.09.022

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  4 in total

1.  The Prevalence and Risk Factors of Osteoporosis among a Saudi Female Diabetic Population.

Authors:  Ibrahim Abdulrazag Al-Homood; Iman Sheshah; Abdel Gaffar A Mohammed; Gasim I Gasim
Journal:  Open Access Maced J Med Sci       Date:  2017-04-08

2.  'Get Healthy!' A physical activity and nutrition program for older adults with intellectual disability: pilot study protocol.

Authors:  Carmela Salomon; Jessica Bellamy; Elizabeth Evans; Renae Reid; Michelle Hsu; Scott Teasdale; Julian Trollor
Journal:  Pilot Feasibility Stud       Date:  2018-08-25

3.  Observed Dietary Intake in Adults with Intellectual Disability Living in Group Homes.

Authors:  Nur Hana Hamzaid; Helen T O'Connor; Victoria M Flood
Journal:  Nutrients       Date:  2019-12-22       Impact factor: 5.717

Review 4.  A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome.

Authors:  Jessica Duis; Mark Nespeca; Jane Summers; Lynne Bird; Karen G C B Bindels-de Heus; M J Valstar; Marie-Claire Y de Wit; C Navis; Maartje Ten Hooven-Radstaake; Bianca M van Iperen-Kolk; Susan Ernst; Melina Dendrinos; Terry Katz; Gloria Diaz-Medina; Akshat Katyayan; Srishti Nangia; Ronald Thibert; Daniel Glaze; Christopher Keary; Karine Pelc; Nicole Simon; Anjali Sadhwani; Helen Heussler; Anne Wheeler; Caroline Woeber; Margaret DeRamus; Amy Thomas; Emily Kertcher; Lauren DeValk; Kristen Kalemeris; Kara Arps; Carol Baym; Nicole Harris; John P Gorham; Brenda L Bohnsack; Reid C Chambers; Sarah Harris; Henry G Chambers; Katherine Okoniewski; Elizabeth R Jalazo; Allyson Berent; Carlos A Bacino; Charles Williams; Anne Anderson
Journal:  Mol Genet Genomic Med       Date:  2022-02-11       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.